# CSL Behring AG – FDA Inspection, Apr 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/csl-behring-ag/f926487f-2e44-4432-98c7-9602dc241d81
Source feed: FDA_Inspections

> FDA inspection 1057840 of CSL Behring AG, April 13, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1057840
- Company Name: CSL Behring AG
- Inspection Date: 2018-04-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1121637 - 2020-02-18](https://www.keypedia.com/records/fda_inspections/csl-behring-ag/efbc8f3e-ac1a-4bf9-95eb-afb9f2185271)
- FDA Inspection 990288 - 2016-09-29
- FDA Inspection 890258 - 2014-06-19
- FDA Inspection 769044 - 2012-02-02
- FDA Inspection 645082 - 2010-01-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)
- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)

Company: https://www.keypedia.com/companies/csl-behring-ag/e5513eac-b911-45b6-b707-dae3d0376210

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d